Stockscreener 앱 받기
0.4152
0.19%
-0.0008
시간 외 거래:
.42
0.0048
+1.16%
Glycomimetics Inc 주식(GLYC)의 최신 뉴스
StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World
GlycoMimetics: Q3 Earnings Snapshot - Darien Times
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 - Quantisnow
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders - The Malaysian Reserve
GlycoMimetics and Crescent Biopharma Update Investor Presentation in Connection with Proposed Merger - Defense World
RA Capital Management's Strategic Acquisition of GlycoMimetics I - GuruFocus.com
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting - BioSpace
GlycoMimetics to Present Major AML Drug Trial Data at ASH 2024 Conference | GLYC Stock News - StockTitan
Top 3 Penny Stocks to Watch Today – October 31, 2024 - The Global Domains News
GlycoMimetics (NASDAQ:GLYC) Now Covered by StockNews.com - Defense World
Shares of Biotech Company Up Over 100% Premarket Following Merger & Funding Announcement - MSN
INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC - WICZ
INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders - Marketscreener.com
What Do Wall Street Analysts Think About GlycoMimetics Inc (NASDAQ: GLYC) Stock? - Stocks Register
INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc.GLYC - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders - The Malaysian Reserve
GlycoMimetics’ Acquisition of Crescent Biopharma - Global Legal Chronicle
GlycoMimetics, Canaan, PayPal: 3 Stocks Retail Is Most Bullish On Today - MSN
GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc.GLYC - Business Wire
3 Penny Stocks to Watch Now, 10/31/24 - TipRanks
GlycoMimetics Announces Merger Agreement with Crescent Biopharma: A Look at the Details - Defense World
GlycoMimetics To Acquire Crescent Biopharma - FinSMEs
Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm - Morningstar
GlycoMimetics soars on news of M&A deal with Crescent Biopharma - The Pharma Letter
GlycoMimetics Announces Merger with Crescent Biopharma - Yahoo Finance
GlycoMimetics Insider Confidence Rewarded, Stock Hits US$11m Market Cap - Simply Wall St
Alphabet, Integrated Media, GlycoMimetic: 3 Stocks Making Retail Most Bullish Pre-Market Today - Barchart
Biotech Up Over +100% Premarket Following Merger And Funding Announcement - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CPTN, GLYC, ARC on Behalf of Shareholders - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Profire Energy, Inc. (Nasdaq – PFIE), Cepton, Inc. (Nasdaq – CPTN), GlycoMimetics, Inc. (Nasdaq – GLYC), ARC Document Solutions, Inc. (NYSE – ARC) - ForexTV.com
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results - Benzinga
GlycoMimetics Stock Triples To Become Top Gainer On Crescent Biopharma Merger Deal: Retail Goes Wild - Barchart
GlycoMimetics Shares Are Soaring Tuesday: Here's Why - Benzinga
Crescent Inks Oncology Merger With $200M In Private Funding - Law360
TSX Smallcap Select Index (TXSC) QuotePress Release - The Globe and Mail
GlycoMimetics Agrees to Acquire Crescent Biopharma - MarketWatch
Crescent rolls up to Glycomimetics merger, $200M in new bread - BioWorld Online
Shareholder Alert: Ademi LLP Investigates Whether GlycoMimetics, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE and GLYC on Behalf of Shareholders - Marketscreener.com
TSX 60 ESG Index (TSXE) QuotePress Release - The Globe and Mail
US Stocks Mixed; McDonald's Posts Upbeat Earnings - Benzinga
TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail
Crescent inks GlycoMimetics merger, securing Nasdaq listing and $200M for hot cancer program - Fierce Biotech
GlycoMimetics skyrockets on buyout deal - MSN
Rockville biotech GlycoMimetics to be acquired - The Business Journals
GLYC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of GlycoMimetics, Inc. Is Fair to Shareholders - Business Wire
GlycoMimetics enters acquisition agreement with Crescent Biopharma - TipRanks
GlycoMimetics Agrees to Be Taken Private by Crescent Biopharma - MarketWatch
Glycomimetics Shares Fall After Leukemia Treatment Trial Misses Key Goal - MarketWatch
GlycoMimetics to acquire Crescent Biopharma in a strategic merger - Investing.com
GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma - Business Wire
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Business Wire
GlycoMimetics to acquire Crescent Biopharma in a strategic merger By Investing.com - Investing.com Canada
S&P 500 Energy [Sector] (SREN) QuotePress Release - The Globe and Mail
Analytical Lens: Exploring GlycoMimetics Inc (GLYC)’s Financial Story Through Ratios - The Dwinnex
TD Cowen downgrades GlycoMimetics Inc (GLYC) rating to a Hold - Knox Daily
3.66%
1.11%
자본화:
|
볼륨(24시간):